WeightWatchers CEO who oversaw diet company's move into weight loss drugs abruptly leaves role
WeightWatchers is shaking up its leadership. WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and former Shake Shack executive,
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
WeightWatchers CEO who oversaw move into weight loss drugs abruptly leaves role
WW International announced Friday that CEO Sima Sistani would leave her role effective immediately. Tara Comonte, a WeightWatchers board member and former Shake Shack executive, was made interim chief executive.
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte has stepped in to serve as interim CEO.
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
WeightWatchers chief executive leaves as company grapples with impact of anti-obesity drugs
WW International, owner of the WeightWatchers dieting business, has said chief executive Sima Sistani is stepping down with immediate effect as the group struggles with the growing popularity of anti-obesity drugs.
Jon Gosselin hit weight loss roadblock after shedding 50 pounds
Jon Gosselin detailed the ebbs and flows of his weight-loss journey, which included semaglutide and weight gain, but he's ...
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
An oral weight loss pill has just passed early trials with promising results—here's how it works
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
Early Study Shows Weight Loss Pill Amycretin May Lead to Significant Results Compared to Ozempic
The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...
Health.com1d
7 Mistakes People Make While Taking Weight Loss Drugs, According to Experts
GLP-1 medications—like Ozempic, Wegovy, and Zepbound—can help you shed pounds, but only if taken properly. Don't get caught ...
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...
Medical News Today2d
Weight-loss surgery may preserve kidney health more effectively than GLP-1 drugs
People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
Are new frozen meals for weight-loss drugs worth it?
Nestle launched frozen meals tailored for people on weight-loss drugs like Ozempic and Wegovy. We tried the teriyaki chicken ...
Combating Obesity With Comprehensive, Patient-Centric Weight Loss Solutions
Obesity is a global health crisis, increasing the risk of chronic conditions like diabetes, heart disease, and metabolic ...